Medical News

RSS

The Wall Street Journal: Medicare records show trail of troubling surgeries

The Wall Street Journal continues its examination of Medicare's claims databases to uncover potentially fraudulent activities. Meanwhile, The Miami Herald reports on one alleged fraud perpetrator who is now awaiting trail.

30 Mar 2011

Positive preliminary results from Presidio's PPI-461 Phase 1b trial against HCV

Presidio Pharmaceuticals, Inc. announced today positive preliminary results from a Phase 1b clinical trial of PPI-461, a novel HCV NS5A inhibitor for the treatment of patients with chronic hepatitis C.

30 Mar 2011

Pelvic arterial embolization therapy effective treatment for postpartum hemorrhage

Pelvic arterial embolization or PAE, a minimally invasive, life-saving therapy, is a safe and effective treatment for postpartum hemorrhage, say researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

New research measures direct radiation doses in patients during endovascular procedures

New research published in the April 2011 issue of the Journal of Vascular Surgery®, the official publication of the Society for Vascular Surgery®, directly measured the radiation doses for patients and operators during complex endovascular procedures.

30 Mar 2011

Valeant receives European Commission marketing authorization for Trobalt

Meda's partner for retigabine, Valeant Pharmaceuticals International, Inc., today announced that the European Commission has granted the marketing authorization for Trobalt™ (retigabine) in the epilepsy therapy area.

30 Mar 2011

Research: Women's body appreciation indirectly connected to their BMI

Women's appreciation of their bodies is only indirectly connected to their body mass index (BMI), a common health measure of weight relative to height, according to recent research.

30 Mar 2011

Cephalon receives unsolicited proposal from Valeant

Cephalon, Inc. confirmed today that it received an unsolicited proposal from Valeant Pharmaceuticals International, Inc., on March 18th to acquire the Company for $73 per share and a second unsolicited proposal on March 25th to either acquire the Company for $73 per share or to purchase Cephalon's non-oncology related assets for $2.8 billion. On March 29th, Valeant announced an unsolicited proposal to acquire all of the outstanding shares in the Company for $73 per share.

30 Mar 2011

Navy sonar experts develop new medical device for stroke detection

A medical device developed by retired U.S. Navy sonar experts, using submarine technology, is a new paradigm for the detection, diagnosis and monitoring of stroke, says a team of interventional radiologists at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago, Ill.

30 Mar 2011

Attacks by specific type of immune cells cause inflammations of heart muscle

Scientists of the German Cancer Research Center, jointly with colleagues in the United States, have found out that inflammations of the heart muscle are caused by attacks of a specific type of immune cells. These immune cells attack the body's own tissue because during their maturation they did not have the chance to develop tolerance against a protein that is only found in the heart muscle.

30 Mar 2011

Stanford pediatrics receives Genzyme/ACMG award for biochemical genetic research

Anna-Kaisa Niemi, MD, Ph.D., a resident in Medical Genetics in the Department of Pediatrics, Division of Medical Genetics at the Stanford University Medical Center, in Stanford Calif., was honored as the 2011-2012 recipient of the Genzyme/American College of Medical Genetics Foundation Clinical Genetics Fellowship in Biochemical Genetics at the ACMG 2011 Annual Clinical Genetics Meeting in Vancouver, BC, Canada.

30 Mar 2011

Multiple drugs bonded to 'transport vehicle' bypass healthy cells to attack breast cancer from inside

Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have employed a strategy using a mouse model to target important mechanisms inside the most challenging breast cancer cells. Earlier studies at Cedars-Sinai found a similar approach effective in attacking malignant brain tumor targets.

30 Mar 2011

Covidien to present new laparoscopic surgical products data at SAGES 2011

Covidien, a leading global provider of healthcare products, announced that new data on its laparoscopic surgical products will be presented at SAGES 2011, the annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons.

30 Mar 2011

Health law policy details continue to grab attention, headlines

Health law costs, accountable care organizations, the individual mandate and even the latest in proceedings surrounding Virginia's health law challenge are all in today's news.

30 Mar 2011

ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI

Oral antiplatelet therapy Effient has been added to the updated clinical practice guidelines as a Class I recommended treatment option for patients undergoing percutaneous coronary intervention fter experiencing heart-related chest pain at rest or non-ST segment elevation myocardial infarction.

30 Mar 2011

Hospital execs among California's highest-paid public employees

Meanwhile, Reuters reports on a common theme in efficiency and cost-cutting among the nation's top 100 hospitals.

30 Mar 2011

Orthopedic surgeons prefer Genzyme's 3-cycle hyaluronic-acid in the U.S., Europe

According to a comprehensive global survey of orthopedic surgeons conducted by iData Research, the leading authority in medical device and pharmaceutical market research, orthopedic surgeons prefer 3-cycle hyaluronic-acid viscosupplementation treatment in the U.S., Europe and Latin Ameica, but are willing to try single-injection products such as Synvisc-One from Genzyme and MONOVISC from Anika Therapeutics.

30 Mar 2011

Prostatic artery embolization comparable to transurethral resection

A new interventional radiology treatment that blocks blood supply to men's enlarged prostate glands shows comparable clinical results to transurethral resection of the prostate (or TURP), considered the gold standard (or most common) treatment. However, this minimally invasive treatment-prostatic artery embolization-has none of the risks associated with TURP, such as sexual dysfunction, urinary incontinence, blood loss and retrograde ejaculation, noted researchers at the Society of Interventional Radiology's 36th Annual Scientific Meeting in Chicago.

30 Mar 2011

Prostate Oncology Specialists introduces new blog for patients

Prostate Oncology Specialists, Inc. announces the launch of the "Prostate Snatchers" blog. It features contributions from a medical oncologist, Mark Scholz MD, who specializes only in prostate cancer and a prostate cancer patient, Ralph H. Blum.

30 Mar 2011

Study examines plant-soil relationship and uptake of contaminants in ryegrass

The environmental concern is great when considering the role of toxic contaminants in the plant-soil relationship. Understanding plant's absorption and accumulation of these contaminants from the soil would be incredibly beneficial.

30 Mar 2011

Chase Foundation donates $2.125 million to UCLA's Child Life program

The Chase Foundation, a nonprofit dedicated to financially supporting hospital-based programs that cater to the social, emotional and developmental needs of children, has donated $2.125 million to the Child Life/Child Development program at Mattel Children's Hospital UCLA.

30 Mar 2011